elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28372484-C3358B56-C363-4204-9835-3DE7BC7C7BD9
Q28372484-C3358B56-C363-4204-9835-3DE7BC7C7BD9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28372484-C3358B56-C363-4204-9835-3DE7BC7C7BD9
Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer
P2860
Q28372484-C3358B56-C363-4204-9835-3DE7BC7C7BD9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28372484-C3358B56-C363-4204-9835-3DE7BC7C7BD9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8e5be5c7f65180113187ade3741b237f87438658
P2860
Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen